Recombinant Human MEIS1 Protein，His

MEIS1, a member of the Meis/Pre-B-cell leukemia homeobox (PBX) family of transcription factors, plays a crucial role in various developmental processes, including limb patterning, hematopoiesis, and neurogenesis. Its dysregulation has been linked to several hematological malignancies and developmental disorders. The search for effective therapeutic strategies to target MEIS1 in cancer has gained momentum, particularly as recent studies suggest its involvement in the stemness and differentiation of leukemia stem cells. MEIS1 operates primarily through the regulation of gene expression by interacting with other transcription factors, such as PBX1, and modulating chromatin remodeling. Understanding the molecular mechanisms governing MEIS1 function is critical for deciphering its role in cellular processes and disease states. Recent advances in recombinant protein technologies have enabled the production of MEIS1 in functional forms, facilitating the study of its structure-function relationships and interaction networks in vitro. By generating recombinant MEIS1 protein, researchers aim to elucidate its biological activities and potential as a therapeutic target. This research is significant not only for revealing the complexities of transcriptional regulation in development and cancer but also for opening new avenues for intervention in MEIS1-associated pathologies. As such, the study of MEIS1 recombinant proteins is poised to contribute substantially to our understanding of both fundamental biological mechanisms and the development of novel therapeutic approaches.